Numerion Labs
numerionlabs.ai
Actively hiring
Computer Vision
Drug Discovery AI
Drug Discovery
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Backers
3
Y Combinator, DCVC
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Tractionpublic signals, read monthly
Web presence
top 8%
of 133.2M domains by links, Common Crawl
Backed byfrom the funds' portfolios and accelerator catalogs
Y Combinator 
DCVC 
Draper Associates Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Genesis Molecular AI is a drug discovery company headquartered in Burlingame, California, and founded in 2019. The company combines deep…
Relation Therapeutics is a London biotechnology company founded in 2019 that applies graph machine learning to disease biology. Its…
Menten AI designs peptide therapeutics using computational protein design combined with quantum and classical optimisation. Founded in 2018…
From idea to drug molecule in days™. Tell our agent your target and it will handle the rest. The first fully autonomous drug discovery…
PostEra uses machine learning for medicinal chemistry, proposing synthesis routes and analogues for drug discovery programmes. Founded in…
Avicenna Biosciences is a drug development company using machine learning-enhanced medicinal chemistry to accelerate the lead-to-candidate…
Overview
Atomwise is a San Francisco company founded in 2012 that pioneered the use of convolutional neural networks for structure-based small molecule discovery. Its screening system evaluates billions of virtual compounds against protein targets to shortlist candidates for synthesis and testing. The company runs internal programmes and collaborates with pharmaceutical partners and academic groups on difficult targets.
News
Numerion Labs Publishes Breakthrough AI Research on Ultra-Fast Screening of Hyper-Scalable Virtual Libraries with NVIDIA
APEX Protocol Enables Exhaustive Evaluation of 10 Billion Virtual Compounds in Under 30 Seconds San Francisco, CA - October 29, 2025 - Numerion Labs, an AI-native company pioneering the application of AI/ML to drug discovery, today announced the release o
Read more
Report
Atomwise, Hansoh Pharma Enter Into Up-to-$1.5B AI-Based Drug Discovery Partnership
Atomwise and Jiangsu Hansoh Pharmaceutical Group-the Chinese company behind this year's largest biopharma initial public offering (IPO)-said today they have launched an up-to-$1.5 billion collaboration to design and discover potential drug candidates for
Read more
Report
Atomwise and China's Hansoh announce potential $1.5bn AI drug discovery deal
Atomwise and Hansoh Pharma have announced an artificial intelligence (AI) drug discovery deal that could be worth $1.5 billion, the largest US-China collaboration in the field.
Read more
Report
Atomwise and Enamine to Advance Pediatric Oncology With the World's First and Largest Ten Billion Compound Virtual Screen
Read more
Report
YC Partners With Atomwise to Fund More Bio Companies Y Combinator
In the last 10 years, the tools for studying biology have become much lessexpensive and more widely available. This has made it possible for new startupsto do serious research right from the start, and it is leading to an explosionof biotech startups.One
Read more
Report
Deep learning startup Atomwise raises $45M
Atomwise, which uses deep learning to shorten the process of discovering new drugs, has raised a $45 million Series A. The round was led by Monsanto Growth Ventures, Data Collective (DCVC) and B Capital Group. Baidu Ventures, Tencent and Dolby Family Vent
Read more
Report
Show more news
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
San Francisco
United States
HQ